PledPharma inrättar vetenskapligt råd inför den fortsatta kliniska utvecklingen av PledOx®
August 24, 2017 02:00 ET
|
PledPharma AB
Stockholm, 2017-08-24 08:00 CEST (GLOBE NEWSWIRE) --
PledPharma meddelar idag att en rad internationellt ledande experter tar plats i ett nyinrättat vetenskapligt råd, med uppdrag att stödja...
PledPharma establishes a Scientific Advisory Board for the continued clinical development of PledOx®
August 24, 2017 02:00 ET
|
PledPharma AB
Stockholm, 2017-08-24 08:00 CEST (GLOBE NEWSWIRE) --
PledPharma announces today that a number of internationally leading experts will join in a newly established Scientific Advisory Board to...
PledPharma rekryterar ny Chief Medical Officer
August 17, 2017 02:00 ET
|
PledPharma AB
Stockholm, 2017-08-17 08:00 CEST (GLOBE NEWSWIRE) --
PledPharma meddelar idag att dr Stefan Carlsson rekryterats till en nyinrättad position som Chief Medical Officer & Vice President Clinical...
PledPharma appoints a Chief Medical Officer
August 17, 2017 02:00 ET
|
PledPharma AB
Stockholm, 2017-08-17 08:00 CEST (GLOBE NEWSWIRE) --
PledPharma announces today that Dr. Stefan Carlsson has been appointed to the newly created position as Chief Medical Officer & Vice...
PledPharma förstärker ledningsgruppen med ny Vice President Product Strategy and Development
June 29, 2017 02:00 ET
|
PledPharma AB
Stockholm, 2017-06-29 08:00 CEST (GLOBE NEWSWIRE) --
PledPharma meddelar idag att Christian Sonesson rekryterats till en nyinrättad position som Vice President Product Strategy and Development....
PledPharma strengthens the management team with a Vice President Product Strategy and Development
June 29, 2017 02:00 ET
|
PledPharma AB
Stockholm, 2017-06-29 08:00 CEST (GLOBE NEWSWIRE) --
PledPharma announces today that Christian Sonesson has been appointed to the newly created position as Vice President Product Strategy and...
Nicklas Westerholm takes office as CEO of PledPharma and signs 500,000 warrants
June 16, 2017 02:00 ET
|
PledPharma AB
Stockholm, 2017-06-16 08:00 CEST (GLOBE NEWSWIRE) --
PledPharma announces that Nicklas Westerholm today assumed the position as the company's CEO. Nicklas Westerholm comes from AstraZeneca, where...
Nicklas Westerholm tillträder som verkställande direktör i PledPharma och tecknar 500 000 teckningsoptioner
June 16, 2017 02:00 ET
|
PledPharma AB
Stockholm, 2017-06-16 08:00 CEST (GLOBE NEWSWIRE) --
PledPharma meddelar att Nicklas Westerholm idag tillträder som bolagets verkställande direktör. Han kommer närmast från AstraZeneca, där han...
Första patienten inkluderad i PledPharmas kliniska studie med Aladote®
June 08, 2017 09:45 ET
|
PledPharma AB
Stockholm, 2017-06-08 15:45 CEST (GLOBE NEWSWIRE) --
PledPharma meddelar idag att den första patienten har inkluderats i den kliniska studien med Aladote® – en läkemedelskandidat avsedd...
First patient included in PledPharma's clinical trial with Aladote®
June 08, 2017 09:45 ET
|
PledPharma AB
Stockholm, 2017-06-08 15:45 CEST (GLOBE NEWSWIRE) --
Today, PledPharma announces that the first patient has been included in the clinical study with Aladote® - a drug candidate intended to reduce...